Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

INDIANAPOLIS – Mild cognitive impairment, which occurs in about one in six individuals in the U.S., age 65 and older, remains substantially underdiagnosed, especially in disadvantaged populations.

MOXO360™ represents a breakthrough in how attention, executive function, and learning abilities are measured and understood. Unlike traditional tests that focus solely on symptom-based diagnostics, ...

Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...

A study recently published in the Journal of Alzheimer's Disease highlights how efficiently digital assessments can uncover the earliest signs of cognitive impairment – likely years before traditional ...

Difficulties with neurocognitive function occur in up to 90% of patients with brain tumors at some point during the disease course and are a major detractor from overall quality of life. Screening ...